Andrew J. McLachlan

ORCID: 0000-0003-4674-0242
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pharmaceutical Practices and Patient Outcomes
  • Musculoskeletal pain and rehabilitation
  • Health Systems, Economic Evaluations, Quality of Life
  • Pharmacogenetics and Drug Metabolism
  • Antibiotics Pharmacokinetics and Efficacy
  • Pharmaceutical studies and practices
  • Pain Management and Opioid Use
  • Pain Mechanisms and Treatments
  • Opioid Use Disorder Treatment
  • Spine and Intervertebral Disc Pathology
  • Drug Transport and Resistance Mechanisms
  • Pain Management and Placebo Effect
  • Drug-Induced Hepatotoxicity and Protection
  • Antifungal resistance and susceptibility
  • Pharmaceutical Economics and Policy
  • Blood Pressure and Hypertension Studies
  • Patient Safety and Medication Errors
  • Pharmacological Effects and Toxicity Studies
  • Medication Adherence and Compliance
  • Renal Transplantation Outcomes and Treatments
  • Antibiotic Use and Resistance
  • Schizophrenia research and treatment
  • Inflammatory mediators and NSAID effects
  • Complementary and Alternative Medicine Studies
  • Anesthesia and Pain Management

The University of Sydney
2016-2025

Concord Repatriation General Hospital
2014-2023

Counties Manukau District Health Board
2012-2023

Pharmac
2020

Association for Jewish Studies
2020

St Vincent's Hospital Sydney
1994-2019

Concord Hospital
2009-2018

National Health and Medical Research Council
2011-2018

Nepean Hospital
2018

Westmead Hospital
2018

Atrial fibrillation (AF) causes a third of all strokes, but often goes undetected before stroke. Identification unknown AF in the community and subsequent anti-thrombotic treatment could reduce stroke burden. We investigated screening for using an iPhone electrocardiogram (iECG) pharmacies, determined cost-effectiveness this strategy.Pharmacists performedpulse palpation iECG recordings, with cardiologist over-reading. General practitioner review/12-lead ECG was facilitated suspected new AF....

10.1160/th14-03-0231 article EN Thrombosis and Haemostasis 2014-01-01

Evidence about the association between treatment with high–risk medicines and frailty in older individuals is limited. We investigated relationship prescribing at baseline, as well 2–year incident frailty, 1,662 men ≥70 years of age. High–risk was defined polypharmacy (≥5 medicines), hyperpolypharmacy (≥10 by Drug Burden Index (DBI), a dose–normalized measure anticholinergic sedative medicines. At frail participants had adjusted odds ratios (ORs) 2.55 (95% confidence interval, CI: 1.69–3.84)...

10.1038/clpt.2011.258 article EN Clinical Pharmacology & Therapeutics 2012-02-01

Voriconazole is a first-line agent in the treatment of many invasive fungal infections and known to display highly variable pharmacokinetics. Previous studies voriconazole therapeutic drug monitoring (TDM) have suggested concentration be clinically useful but been limited by small patient samples at single institution. This multicenter retrospective study aimed investigate relationships between clinical outcomes adverse events assess factors interactions that may affect concentration....

10.1128/aac.00626-12 article EN Antimicrobial Agents and Chemotherapy 2012-07-03

Sciatica can be disabling, and evidence regarding medical treatments is limited. Pregabalin effective in the treatment of some types neuropathic pain. This study examined whether pregabalin may reduce intensity sciatica.We conducted a randomized, double-blind, placebo-controlled trial patients with sciatica. Patients were randomly assigned to receive either at dose 150 mg per day that was adjusted maximum 600 or matching placebo for up 8 weeks. The primary outcome leg-pain score on 10-point...

10.1056/nejmoa1614292 article EN New England Journal of Medicine 2017-03-22

Aim The aim of this study was to investigate the effect St John's wort and ginseng on pharmacokinetics pharmacodynamics warfarin. Methods This an open‐label, three‐way crossover randomized in 12 healthy male subjects, who received a single 25‐mg dose warfarin alone or after 14 days’ pretreatment with wort, 7 ginseng. Dosing continued for days administration dose. Platelet aggregation, international normalized ratio (INR) prothrombin time, enantiomer protein binding, concentrations plasma...

10.1111/j.1365-2125.2003.02051.x article EN British Journal of Clinical Pharmacology 2004-02-03

Scope and purpose of the guidelinesThe clinical presentation a hot swollen joint is common has wide differential diagnosis.The most serious septic arthritis, with case fatality 11%.Delayed or inadequate treatment leads to damage.These guidelines focus on diagnosis management arthritis.Hot joints commonly have other underlying diagnoses, including crystal reactive arthritis monoarticular polyarthritis.

10.1093/rheumatology/kel163a article EN Lara D. Veeken 2006-07-06

The aim of this study was to investigate the effect two common herbal medicines, ginkgo and ginger, on pharmacokinetics pharmacodynamics warfarin independent these herbs clotting status.

10.1111/j.1365-2125.2005.02322.x article EN British Journal of Clinical Pharmacology 2005-02-09
Coming Soon ...